Signaling mediated by the mammalian target of rapamycin kinase (mTOR) is activated during human cytomegalovirus (HCMV) infection. mTOR is found in two complexes differing by the binding partner, rictor or raptor. Activated mTOR-raptor promotes capdependent translation through the hyperphosphorylation of the eIF4E-binding protein (4E-BP). This activity of the raptor complex is normally inhibited by cell stress responses or the drug rapamycin. However, we previously showed that this inhibition of mTOR signaling can be circumvented during HCMV infection such that hyperphosphorylation of 4E-BP is maintained. Here we show that HCMV infection also activates the rictor complex, as indicated by increased phosphorylation of Akt S473; this phosphorylation is insensitive to rapamycin but sensitive to caffeine in both uninfected and infected cells. By using short-hairpin RNAs to deplete rictor and raptor, we find that rictor is more significant than raptor for the viral infection. Surprisingly, the inhibitory effects of rapamycin on viral growth are primarily due to the presence of rictor, not raptor. Raptor and rictor depletion experiments show that in HCMV-infected cells, both raptor-and rictor-containing complexes can mediate the hyperphosphorylation of 4E-BP and the phosphorylation of p70S6 kinase. Under these conditions, the rictor complex is rapamycin-sensitive for the hyperphosphorylation of 4E-BP, but the raptor complex is not. These data suggest that, during HCMV infection, the rictor-and raptor-containing complexes are modified such that their substrate specificities and rapamycin sensitivities are altered. Our data also suggest that the present understanding of rapamycin's inhibitory effects is incomplete. T he mammalian target of rapamycin kinase (mTOR) is a component of two complexes that differ in the regulatory partner ( Fig. 1) , raptor in mTOR complex 1 (mTORC1, or the raptor complex) and rictor in mTOR complex 2 (mTORC2, or the rictor complex; refs. 1-3). A third protein, G␤L, binds to the kinase domain of mTOR and stabilizes the interaction with the binding partners (4). The raptor complex is a major controller of cap-dependent translational initiation. Its activation (Fig. 1) results from Akt phosphorylation of the tuberous sclerosis complex (TSC1 and -2, reviewed in ref. 5). This phosphorylation relieves TSC's GTPase activating protein (GAP) function, allowing the accumulation of Rheb GTP, which then binds mTOR, allowing activation of the raptor complex in a GTP-dependent manner (5-7). The activated raptor complex increases translation by phosphorylating its targets, the eIF4E-binding protein (4E-BP), p70S6 kinase (S6K), and eIF4G. These mTOR activities are inhibited by rapamycin.
T he mammalian target of rapamycin kinase (mTOR) is a component of two complexes that differ in the regulatory partner ( Fig. 1) , raptor in mTOR complex 1 (mTORC1, or the raptor complex) and rictor in mTOR complex 2 (mTORC2, or the rictor complex; refs. [1] [2] [3] . A third protein, G␤L, binds to the kinase domain of mTOR and stabilizes the interaction with the binding partners (4) . The raptor complex is a major controller of cap-dependent translational initiation. Its activation (Fig. 1 ) results from Akt phosphorylation of the tuberous sclerosis complex (TSC1 and -2, reviewed in ref. 5 ). This phosphorylation relieves TSC's GTPase activating protein (GAP) function, allowing the accumulation of Rheb GTP, which then binds mTOR, allowing activation of the raptor complex in a GTP-dependent manner (5) (6) (7) . The activated raptor complex increases translation by phosphorylating its targets, the eIF4E-binding protein (4E-BP), p70S6 kinase (S6K), and eIF4G. These mTOR activities are inhibited by rapamycin.
Phosphorylation of S6K by the raptor complex activates its ability to phosphorylate ribosomal protein S6, which correlates with increased ribosome biogenesis (8) . The hyperphosphorylation of 4E-BP prevents it from binding eIF4E (the cap-binding protein), allowing eIF4E to be maintained in the active eIF4F cap-binding complex, which also contains eIF4G, eIF4A, and the kinase Mnk1 (Fig. 1 ). This intact complex binds to capped mRNA for translational initiation. Inhibition of mTOR, e.g., by stress or rapamycin, results in hypophosphorylation of 4E-BP, which allows eIF4E binding and displacement from the eIF4F complex. This displacement results in the inhibition of capdependent translation.
The rictor complex has been characterized more recently (2); thus, its functions and mechanisms of control have not been fully defined. However, its substrate specificity in normal cells differs from the raptor complex. In normal cells, it is not upstream of S6K but has been reported to function upstream of Rho GTPase to regulate the actin cytoskeleton (3). At present, the rictor complex's only established substrate is S473 of Akt (9) . The phosphorylation of S473 is rapamycin-insensitive (2, 3) and caffeine-sensitive (10) .
Human cytomegalovirus (HCMV) is a slow-growing ␤-herpesvirus that must maintain beneficial host cell functions for an extended period. However, as the infection proceeds, increased metabolism and synthesis of viral proteins induce cellular stress responses, which would normally result in decreased metabolism and inhibition of translation (11, 12) . However, we have shown that HCMV induces mechanisms that can circumvent the inhibition of translation caused by many stresses (13, 14) . For example, the HCMV major immediate early proteins activate the phosphatidylinositide 3Ј-OH kinase͞Akt pathway (15) , leading to the activation of mTOR ( Fig. 1 ) and the maintenance of cap-dependent translation. Nevertheless, as discussed above, this pathway to mTOR activation can be inhibited by stress or rapamycin. However, HCMV infection circumvents this problem by inducing a stress-and rapamycin-insensitive mechanism that maintains 4E-BP hyperphosphorylation and cap-dependent translation (14, 16) .
In the experiments presented herein, we examined the mechanism whereby HCMV induces rapamycin-insensitive phosphorylation of 4E-BP by assessing the roles of the raptor and rictor complexes by using systematic depletion by short-hairpin RNAs (shRNAs). The data suggest that, during HCMV infection, rictor-and raptor-containing complexes are modified such that their substrate specificities and rapamycin sensitivities are altered. Our data suggest that the present understanding of rapamycin's inhibitory effects is incomplete. That sensitivity to the drug can be altered by viral infection suggests such alterations may also be mediated by inducible cellular mechanisms.
Results
shRNAs for Rictor, Raptor, and mTOR Are Effective in HCMV-Infected Cells. Lentiviral vectors encoding shRNAs previously shown to effectively deplete mTOR, rictor, or raptor (9) were introduced into human foreskin fibroblasts (HFFs) to determine their effectiveness during HCMV infection. Seven days after lentiviral infection (including 48 h of serum starvation), the cells were infected for 0, 10, and 24 h with purified (serum-free) HCMV [multiplicity of infection (moi) ϭ 2] in no drug, 50 nM rapamycin, or 1.7 mM caffeine under serum-free conditions, as described in Materials and Methods.
Western blot analyses (Fig. 2) for each protein were performed on samples prepared from simultaneously executed experiments, transferred, and analyzed in parallel with the same exposures to film. Actin analyses showed consistent loading (not shown).
The data for mTOR show that its levels were significantly reduced (compared with the control shRNA or no shRNA) at all infection time points by mTOR shRNA but not by the other shRNAs. Likewise, raptor levels were significantly reduced by the raptor shRNA. In both cases, the presence of rapamycin or caffeine had little effect on the levels of mTOR or raptor under any condition. These data show that the mTOR and raptor shRNAs function effectively in HFFs and are not affected by HCMV infection. Interestingly, none of the shRNAs resulted in a significant decrease in the expression of the HCMV major intermediate early proteins, suggesting that the viral infection initiated normally.
We could not obtain an adequate antibody for the detection of rictor; therefore, we functionally analyzed the potency of the rictor shRNA by determining its effect on the phosphorylation of S473 of Akt, the rictor substrate (9) . In uninfected cells, the phosphorylation of S473 has been shown to be significantly inhibited by the shRNAs for mTOR and rictor but not by the shRNA for raptor (9) . In agreement, our data (Fig. 3) show that HCMV-induced phosphorylation of Akt S473 is severely inhibited by the mTOR and rictor shRNAs but not the raptor shRNA. These findings suggest that rictor shRNA can significantly deplete rictor activity levels in HCMV-infected HFFs; this conclusion is supported by the following experiments.
The experiments examining Akt S473 phosphorylation in the presence of the raptor shRNA and the control shRNA provide an additional significant observation. Under the serum-free growth conditions used, HCMV infection activates the rictor complex, as indicated by increased phosphorylation of Akt S473 by 10 h postinfection (hpi). The levels of total Akt do not change Fig. 2 . The effectiveness of shRNAs in diminishing mTOR and rictor in HCMV-infected cells. Lentiviral vectors were used to introduce the various shRNAs in HFF cells, as described in Materials and Methods. The cells were then infected with HCMV for 10 and 24 h in the presence of rapamycin (R), caffeine (C), or no drug (ND). Extracts were subjected to Western blot analysis by using antibodies for mTOR, raptor, and the HCMV major immediate early proteins. significantly during infection (not shown). In agreement with previous data, the S473 phosphorylation induced by HCMV is rapamycin-insensitive and caffeine-sensitive, as shown in 24-h raptor shRNA sample (9, 10).
The Kinetics of Induction of Phosphorylation of Akt S473 by HCMV
Infection Differs from That of Serum Stimulation. In Fig. 4 , we further examined the HCMV-induced phosphorylation of Akt S473 by using serum-starved cells and serum-free infection conditions, as described above. Fig. 4A shows that, within 2 h of HCMV infection, phosphorylation of S473 was induced; this increased by 12 h and persisted through 24 h. As indicated above, this activity was rapamycin (Rap.)-insensitive and caffeine (Caf.)-sensitive at all time points.
We next determined whether the S473 phosphorylation induced by HCMV in serum-starved cells differs from the induction seen during serum stimulation of uninfected cells (Fig. 4B) . In the absence of drugs, there was a transient activation of S473 phosphorylation at 1 h after serum addition that subsided by 2 h. This phosphorylation was not inhibited by rapamycin, consistent with mediation by the rictor complex. Interestingly, in the presence of rapamycin, the stimulation of S473 phosphorylation extended to 4 h after serum stimulation, which has been observed by others (2) but remains unexplained. The rictor complex-mediated phosphorylation of S473 was also inhibited by caffeine in the serum-stimulated uninfected cells. Overall, the data show that phosphorylation of Akt S473 induced by HCMV infection in serum-starved cells is sustained much longer than in serum-stimulated uninfected cells. In addition, S473 phosphorylation is caffeine-sensitive in both infected and uninfected cells.
We have previously reported that the phosphorylation of 4E-BP in serum-starved HCMV-infected cells becomes rapamycin-insensitive between 12 and 24 h after HCMV infection (14) . This observation is summarized by Western blot analysis in Fig.  4C , probing for total 4E-BP. In untreated cells (no drug), hyperphosphorylated 4E-BP (indicated by increased ␤ and ␥ bands) appeared by 12 hpi and was moderately sensitive to rapamycin. However, by 24 hpi, 4E-BP hyperphosphorylation is significantly resistant to rapamycin. In contrast, during serum stimulation of uninfected cells, the hyperphosphorylation of 4E-BP is always sensitive to rapamycin (14) . In addition, in infected cells, the phosphorylation of 4E-BP was not affected by caffeine (not shown). Taken together, the data indicate that the kinetics of induction of phosphorylation of 4E-BP and Akt S473 during HCMV infection differs significantly from serum stimulation.
Rictor Is the Source of Rapamycin Sensitivity for HCMV Growth. The above results and our previous findings (14) suggest that both the rictor and raptor complexes are activated during HCMV infection. To determine the importance of each protein during HCMV infection, we generated HCMV growth curves under conditions of rictor and raptor depletion. HFFs were infected with lentiviral vectors expressing the rictor and raptor shRNAs or the control shRNA. The mTOR shRNA was not used, because cells expressing it do not survive the viral infection time course. After establishing shRNA expression (see Materials and Methods), the cells were infected with HCMV (Towne, moi ϭ 2-3) for various times up to 120 h in the presence or absence of rapamycin. The growth curves for the control shRNA are plotted in both Fig. 5 A and B . In the absence of rapamycin, a relatively normal growth curve was observed (closed circles). In addition, the effects of rapamycin on HCMV growth (open circles) were similar to what we have reported (14) ; there is an initial lag of at least 24 h before the first appearance of progeny viruses, then the infection proceeds rapidly but ends with a lower yield. We believe that the lag indicates a period in which the virus induces mechanisms that circumvent the effects of rapamycin or stress. The yield in this experiment is decreased by Ϸ1 log, which is greater than in growth curves done without shRNAs (14) . We feel that the presence of the lentiviruses and͞or the expression of increased amounts of shRNAs may introduce an added stress, resulting in slightly decreased yields.
Depleting rictor (Fig. 5A , closed squares) caused a significant drop in viral yield, indicating rictor's importance for the viral infection. However, under these conditions, the addition of rapamycin (Fig. 5A, open squares) had no additional effect on the infection. Importantly, there was no lag in the appearance of progeny virions and no additional lowering of the yield. This observation suggests that the presence of rictor results in rapamycin's inhibitory effects on viral growth. This conclusion is supported by the raptor depletion experiment (Fig. 5B, closed  squares) , showing that raptor depletion is less deleterious to viral yield; however, the sensitivity to rapamycin is increased as indicated by a lower yield (Fig. 5B, open squares) .
Together, these data suggest that (i) rictor is more significant than raptor for the viral infection, (ii) the effects of rapamycin on viral growth are primarily due to the presence of rictor, and (iii) when rictor predominates, the sensitivity to rapamycin is increased. These finding are counterintuitive to the indications in the literature that the rictor complex is rapamycin-insensitive and the raptor complex is rapamycin-sensitive (2, 3). Thus, we examined the hypophosphorylation of 4E-BP and the phosphorylation of S6K in infected cells in the presence of mTOR, rictor and raptor depletion. caused at least an 80% reduction in the hyperphosphorylation of 4E-BP (Fig. 6, p4E -BP) at 10 and 24 hpi as compared with the control shRNA experiment. This reduction indicates the importance of mTOR for this activity. In contrast, depletion of either raptor or rictor, in the absence of drugs, decreased hyperphosphorylation by only 30-50%. However, in each case, the residual activity showed specific drug sensitivities. When raptor was depleted, leaving rictor to predominate, the residual activity was sensitive to caffeine, suggesting it is due to rictor. In addition, it is sensitive to rapamycin, reiterating the conclusions of the growth curves that rictor is responsible for rapamycin sensitivity in HCMV-infected cells. If this is correct, then it can be predicted that depletion of rictor, leaving raptor to predominate, should result in the residual 4E-BP hyperphosphorylation being resistant to rapamycin and caffeine, which is seen in Fig. 6 (p4E-BP, rictor shRNA). Little change in total 4E-BP levels was detected under any of the shRNA conditions (not shown). Taken together, the data suggest that (i) during HCMV infection, both raptor-and rictor-containing complexes can mediate the hyperphosphorylation of 4E-BP, and (ii) the rictor-containing complex is rapamycin-sensitive for this activity, and the raptorcontaining complex is not.
In HCMV-Infected Cells, Either a Raptor-or Rictor-Containing Complex
Can Phosphorylate S6K; in both Cases, the Phosphorylation Is Sensitive to Rapamycin. We have shown that the phosphorylation of S6K is activated during HCMV infection (14) . This observation is reiterated in Fig. 6 (pS6K) , in the absence of drugs HCMV infection induced phosphorylation of S6K at 10 and 24 hpi in the control shRNA experiment. In comparison, the depletion of mTOR significantly reduced the HCMV-induced phosphorylation of S6K, indicating the significance of mTOR in this reaction. However, as was seen with 4E-BP, the depletion of either rictor or raptor was less severe, resulting in only a 30-50% reduction at 10 and 24 hpi. These data suggest that in HCMV-infected cells, either raptor-or rictor-containing complexes can phosphorylate S6K. That a rictor-containing complex is involved is supported by the caffeine sensitivity of the residual S6K phosphorylation under conditions of raptor depletion (raptor shRNA). Interestingly, the residual activity under both conditions of depletion is rapamycin-sensitive. Little change in total S6K levels was de- 6 . The effects of shRNA-mediated diminution of rictor and raptor on the phosphorylation of 4E-BP and S6K in HCMV-infected cells in the presence or absence of rapamycin or caffeine. Lentiviral vectors were used to introduce the various shRNA in HFF cells as described in Materials and Methods. The cells were then infected with HCMV for 10 and 24 h in the presence of rapamycin (R), caffeine (C), or no drug (ND). Extracts were subjected to Western blot analysis by using antibodies for phosphorylated 4E-BP (p4E-BP) or phosphorylated S6K (pS6K).
tected under any of the shRNA conditions (not shown). These finding suggest that, although S6K is not a substrate for the rictor complex under normal conditions (17) , it can be a substrate in HCMV-infected cells. Fig. 7 summarizes the conclusions. HCMV infection alters the rapamycin sensitivity and substrate specificity of raptor-and rictor-containing complexes. The raptor-containing complex, which is normally rapamycin-sensitive for phosphorylation of both 4E-BP and S6K, becomes rapamycin-resistant for the phosphorylation of 4E-BP within 24 h of HCMV infection. However, the rapamycin sensitivity of S6K phosphorylation is not altered by infection. This difference suggests that the alteration in rapamycin sensitivity for the raptor-containing complex is substrate-specific.
Discussion
Although 4E-BP or S6K are not known to be substrates of the rictor complex under normal conditions (17) , they are in HCMV-infected cells. This rictor-mediated phosphorylation is rapamycin-sensitive, whereas the rictor complex is normally thought to be insensitive. Thus, HCMV infection modifies the rictor complex such that its substrate specificity and rapamycin sensitivity are altered.
The apparent switch in rapamycin sensitivity of the raptor-and rictor-containing complexes in infected cells was supported by the viral growth curves generated in cells depleted of either raptor or rictor. These data showed that rapamycin's inhibitory effects on HCMV growth result from the presence of rictor and not raptor. In addition, these data suggest that loss of rictor is more deleterious to the viral infection than loss of raptor. This difference may be due to the multiple activities of rictor: Akt phosphorylation as well as phosphorylation of 4E-BP and S6K.
The maintenance of significant levels of 4E-BP and S6K phosphorylation under conditions of either rictor or raptor depletion in infected cells is likely due to the observation that either raptor-or rictor-containing complexes can phosphorylate these substrates in infected cells. Although one complex is depleted, the other may be sufficient to maintain phosphorylation. Additionally, mTOR freed by the depletion of one binding partner may saturate the available amounts of the other, thus restoring activity.
Our data indicate that HCMV infection causes profound changes to a very significant signaling pathway. These changes may have consequences well beyond the effects on translation that brought us to these studies. It is likely that during infection, the mTOR complexes are altered through structural modification or by the addition of viral or cellular regulatory proteins to the complexes, thus changing drug sensitivities and substrate specificities. This latter idea is supported by the observation that mTOR, raptor, rictor, and G␤L all contain repeated sequences, such as HEAT and WD40 domains, which may potentially mediate significant protein-protein interactions (17) with viral proteins or virally induced cellular proteins.
It has been proposed that in yeast, dimerization of rictor complexes occludes rapamycin from its binding site on mTOR, resulting in rapamycin insensitivity (18) . If such dimerization occurs in mammalian cells, it is possible that HCMV infection blocks dimerization, accounting for the acquired rapamycin sensitivity and possibly the gain of 4E-BP and S6K as substrates.
It should also be considered that the mTOR phosphorylation sites on S6K and 4E-BP are different (17) , suggesting that mTOR kinase itself does not recognize substrates, but that rictor and raptor determine substrate preference. Both S6K and 4E-BP contain a conserved short sequence called the TOR signaling (TOS) motif; this motif is recognized by raptor and is required for efficient in vitro and in vivo phosphorylation by the mTORraptor complex (19) . The HCMV-induced alteration in the rictor complex's substrate specificity may result from a viral protein or a virally induced cellular protein, which associates with the rictor complex and brings S6K and 4E-BP to it, possibly by interacting with the TOS motifs. It is also possible that in infected cells, there are no longer two distinct mTOR complexes, but one combined complex in which raptor substrate specificity may be shared with rictor and drug sensitivities are modified.
Finally, DNA viruses like HCMV do not often use novel viral-specific biochemistry. Instead, they induce, modify, mimic, or preempt existing cellular mechanisms. Therefore, we suggest that inducible mechanisms may exist in uninfected cells that can cause raptor and rictor to alter their substrate specificities and rapamycin sensitivities.
Materials and Methods
Reagents. Working stocks of rapamycin and caffeine (Sigma, St. Louis, MO) were, respectively, 100 M (2,000ϫ) in DMSO and 85 mM (50ϫ) in sterile water. Because of the DMSO in the rapamycin stock, all experiments with rapamycin used controls (no drug) that contained an equal aliquote of DMSO. Primary antibodies used were obtained from Cell Signaling Technology (Beverly, MA) except for anti-mTOR (Santa Cruz Biotechnology, Santa Cruz, CA) and the polyclonal sera that recognize the common N-terminal 85 amino acids in all HCMV major immediate early proteins (20) . All secondary antibodies were purchased from Pierce (Rockford, IL). All cell culture reagents were purchased from GIBCO͞BRL (Carlsbad, CA).
Cell Culture. Life-extended HFFs (21) were used between passages 4 and 10 and cultured at 37°C in 5% CO 2 in D10 media (DMEM supplemented with 10% FCS͞100 units/ml penicillin͞ 100 g/ml streptomycin͞2 mM glutamine). All serum-starvation experiments were done in D0 medium, which is D10 medium without the serum.
HCMV Virus.
All infection experiments were done with the Towne strain of HCMV that has been modified by the replacement of a nonessential gene with the gene for GFP expressed from the simian virus 40 promoter (22, 23) . This virus was propagated in life-extended HFFs and purified by ultracentrifugation over D-sorbitol (14) .
shRNA Lentiviruses. Plasmids encoding lentiviruses that express shRNAs against mTOR, raptor, rictor, and a scrambled sequence (Addgene plasmids 1855, 1857, 1853, and 1864, respectively) have been described (2) . Lentiviruses were prepared in 293T cells following established protocols (2) . Supernatants containing viruses were harvested at 48 and 72 h after transfection and clarified by centrifugation at 1,860 ϫ g for 5 min at room temperature. The supernatants were then filtered through 0.45-m Steriflip (Millipore, Billerica, MA) filters and concentrated by ultracentrifugation at 22,000 ϫ g at 4°C for 2 h. Virus pellets were resuspended in D10, aliquoted, flash-frozen in liquid N2, and stored at Ϫ80°C. 
